Expression of Interferon Regulatory Factors (IRF-1 and IRF-2) During Radiation-induced Damage and Regeneration of Bone Marrow by Transplantation in Mouse

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2018 Nov 30

PMID 30488374

Citations 5

Authors

Naseem Ahamad

Pramod C Rath

Affiliations

Soon will be listed here.

Abstract

Interferon regulatory factors (IRF-1 and IRF-2) are transcription factors of IRF-family that regulate expression of genes for cytokines, chemokines and growth factors in mammalian cells. IRF-1 and IRF-2 play crucial roles in the differentiation of bone marrow cells for immune response. Bone marrow (BM) is the soft lymphoid organ that contains many types of stem cells and produces different types of cells of the blood and immune system. Genetic alterations and damage of the bone marrow cells can lead to different types of blood and immune system-related diseases including anemia and cancer. We have studied the expression of IRF-1 and IRF-2 during radiation-induced damage and regeneration of bone marrow cells after transplantation of freshly isolated bone marrow cells in the mouse. Cell cycle analysis, colony forming unit-fibroblast (CFU-F) assay and bone marrow histology showed that after radiation-induced damage, the bone marrow transplantation resulted in regeneration of the bone marrow up to 24-35% recovery. Real-time quantitative reverse transcription-polymerase chain reaction (Q-RT-PCR) for the mRNA expression showed that IRF-1 and IRF-2 were expressed at higher levels in the bone marrow cells of the irradiated (4.34× fold for IRF-1, and 3.87× fold for IRF-2) compared to control and transplanted (1.13× fold for IRF-1, and 1.12× fold IRF-2) mice and immuno-fluorescence analysis for the protein expression showed that IRF-1 and IRF-2 were expressed at higher levels in the bone marrow cells of the irradiated (2.12× fold for IRF-1 and 1.71× fold for IRF-2) compared to control and transplanted (1.73× fold for IRF-1 and 1.21× fold for IRF-2) mice. Thus, IRF-1 and IRF-2 are sensitive and responsive to radiation-induced damage in the bone marrow cells and may also be involved in the bone marrow regeneration process.

Citing Articles

Mesenchymal stem cells (MSCs) from the mouse bone marrow show differential expression of interferon regulatory factors IRF-1 and IRF-2.

Chaudhary J, Ahamad N, Rath P Mol Biol Rep. 2024; 51(1):97.

PMID: 38194130 DOI: 10.1007/s11033-023-09025-9.

Statistical and network analyses reveal mechanisms for the enhancement of macrophage immunity by manganese in infection.

Shan L, Wang Z, Wu L, Qian K, Peng G, Wei M Biochem Biophys Rep. 2023; 37:101602.

PMID: 38155943 PMC: 10753046. DOI: 10.1016/j.bbrep.2023.101602.

Differential activation of Ca influx channels modulate stem cell potency, their proliferation/viability and tissue regeneration.

Ahamad N, Sun Y, Nascimento Da Conceicao V, Xavier Paul Ezhilan C, Natarajan M, Singh B NPJ Regen Med. 2021; 6(1):67.

PMID: 34671058 PMC: 8528841. DOI: 10.1038/s41536-021-00180-w.

Increasing cytosolic Ca levels restore cell proliferation and stem cell potency in aged MSCs.

Ahamad N, Sun Y, Singh B Stem Cell Res. 2021; 56:102560.

PMID: 34624617 PMC: 8596392. DOI: 10.1016/j.scr.2021.102560.

Calcium channels and their role in regenerative medicine.

Ahamad N, Singh B World J Stem Cells. 2021; 13(4):260-280.

PMID: 33959218 PMC: 8080543. DOI: 10.4252/wjsc.v13.i4.260.

References

Tamura T, Yanai H, Savitsky D, Taniguchi T . The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol. 2008; 26:535-84. DOI: 10.1146/annurev.immunol.26.021607.090400. View

Taniguchi T, Ogasawara K, Takaoka A, Tanaka N . IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001; 19:623-55. DOI: 10.1146/annurev.immunol.19.1.623. View

Upreti M, Rath P . Expression and DNA binding activity of the recombinant interferon regulatory factor-1 (IRF-1) of mouse. Mol Biol Rep. 2005; 32(2):103-16. DOI: 10.1007/s11033-004-6940-3. View

Romeo G, Fiorucci G, Chiantore M, Percario Z, Vannucchi S, Affabris E . IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res. 2002; 22(1):39-47. DOI: 10.1089/107999002753452647. View

Zhao G, Jiang D, Li H . Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Biochim Biophys Acta. 2014; 1852(2):365-78. DOI: 10.1016/j.bbadis.2014.04.030. View

Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T . Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009; 15(6):696-700. DOI: 10.1038/nm.1973. View

Perazzio A, Oliveira J, Figueiredo V, Chauffaille M . Increase of IRF-1 gene expression and impairment of T regulatory cells suppression activity on patients with myelodysplastic syndrome: A longitudinal one-year study. Leuk Res. 2017; 55:6-17. DOI: 10.1016/j.leukres.2017.01.008. View

Travlos G . Normal structure, function, and histology of the bone marrow. Toxicol Pathol. 2006; 34(5):548-65. DOI: 10.1080/01926230600939856. View

Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y . Bone marrow and the control of immunity. Cell Mol Immunol. 2011; 9(1):11-9. PMC: 3251706. DOI: 10.1038/cmi.2011.47. View

10.

Yu V, Scadden D . Heterogeneity of the bone marrow niche. Curr Opin Hematol. 2016; 23(4):331-8. PMC: 6819995. DOI: 10.1097/MOH.0000000000000265. View

11.

Poncin G, Beaulieu A, Humblet C, Thiry A, Oda K, Boniver J . Characterization of spontaneous bone marrow recovery after sublethal total body irradiation: importance of the osteoblastic/adipocytic balance. PLoS One. 2012; 7(2):e30818. PMC: 3281884. DOI: 10.1371/journal.pone.0030818. View

12.

Wilke C, Holtan S, Sharkey L, DeFor T, Arora M, Premakanthan P . Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen. Radiother Oncol. 2015; 118(1):65-71. PMC: 4764403. DOI: 10.1016/j.radonc.2015.11.012. View

13.

Cui Y, Hisha H, Yang G, Jin T, Li Q, Lian Z . Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant. 2002; 30(12):843-9. DOI: 10.1038/sj.bmt.1703766. View

14.

Duran-Struuck R, Dysko R . Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci. 2009; 48(1):11-22. PMC: 2694700. View

15.

Liebermann D, Hoffman B . Good and bad IRF-1: role in tumor suppression versus autoimmune disease. Leuk Res. 2009; 33(10):1301-2. DOI: 10.1016/j.leukres.2009.03.038. View

16.

Nascimento F, Gomes E, Russo M, Lepique A . Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity. PLoS One. 2015; 10(2):e0117782. PMC: 4449231. DOI: 10.1371/journal.pone.0117782. View

17.

Paun A, Pitha P . The IRF family, revisited. Biochimie. 2007; 89(6-7):744-53. PMC: 2139905. DOI: 10.1016/j.biochi.2007.01.014. View

18.

Yanai H, Negishi H, Taniguchi T . The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Oncoimmunology. 2012; 1(8):1376-1386. PMC: 3518510. DOI: 10.4161/onci.22475. View

19.

Soleimani M, Nadri S . A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009; 4(1):102-6. DOI: 10.1038/nprot.2008.221. View

20.

Zhu H, Guo Z, Jiang X, Li H, Wang X, Yao H . A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc. 2010; 5(3):550-60. DOI: 10.1038/nprot.2009.238. View